Benign parathyroid adenoma. Benign neoplasm of parathyroid gland
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with symptomatic benign parathyroid adenoma confirmed by ultrasound, MIBI scan, and fine needle aspiration
Exclusion criteria
Exclusion criteria: Patients with MEN1 or MEN2 syndrome Patients with suspected parathyroid malignant adenoma Patients with secondary or tertiary hyperparathyroidism Not willing to participate in the trial GFR<30 ml/min/1.72 m2 age above 50
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum calcium level. Timepoint: Before the intervention, 24 hours, two weeks, three months, and six months after the intervention. Method of measurement: Blood sample tests.;Serum PTH level. Timepoint: Before the intervention, 24 hours, two weeks, three months, and six months after the intervention. Method of measurement: Blood sample tests. | — |
Secondary
| Measure | Time frame |
|---|---|
| Adenoma recurrence (reoperation or re-injection of alcohol). Timepoint: Within 3 months and 6 months after the intervention. Method of measurement: Changes in serum calcium and parathyroid hormone levels after intervention. | — |
Countries
Iran (Islamic Republic of)
Contacts
Esfahan University of Medical Sciences